Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2022

Open Access 01-12-2022 | Craniomandibular Dysfunction and Stress | Research

Evaluation of the efficacy of platelet rich fibrin (I-PRF) intra-articular injections in the management of internal derangements of temporomandibular joints – a controlled preliminary prospective clinical study

Authors: Mustafa Manafikhi, Jawdat Ataya, Omar Heshmeh

Published in: BMC Musculoskeletal Disorders | Issue 1/2022

Login to get access

Abstract

Background

The temporomandibular joint (TMJ) is one of the most complex joints in the body. Temporomandibular disorders (TMD) are among the most troublesome disorders for patients, as they can cause pain, affect oral functions and disturb dentists on the level of diagnosis and treatment. The most common symptoms of temporomandibular joint disorders are articulated sounds (such as clicking or TMJ crepitation), joint pain in comfort and function situations (jaw movements), pain or strain in masseter and jaw muscles and or restricted mandibular movements. One of the most modern biocompatible substances used to treat joint disorders, including the TMJ, is platelet-rich plasma (PRP) and injectable platelet-rich fibrin (I-PRF). This study aims to evaluate the efficacy of platelet-rich fibrin (I-PRF) intra-articular injections in managing internal derangements of temporomandibular.

Methods

Twenty patients suffering from a unilateral click due to temporomandibular disorders were individually injected with 1 mL of (I-PRF) twice 1 week apart into the superior joint space of the TMJ with the internal disorder. Data were recorded and evaluated by the Helkimo index. This evaluation was conducted three times; 1 week after the first injection, 1 week after the second injection, and 6 months after the first injection.

Results

The clicking disappeared entirely in 14 out of 20 patients after 1 week of getting the first injection, and in all patients after 1 week of getting the second injection, and returned to two of them after a six-month since the first injection.

Conclusion

Preliminary results showed the efficacy of the Injectable Platelet-Rich Fibrin (I-PRF) in managing articular clicking in patients with internal disorders of the temporomandibular joint. Injectable Platelet Rich Fibrin has significant clinical efficacy in treating the articular clicking resulting from internal temporomandibular joint disorders.
Literature
1.
Alomar X, Medrano J, Cabratosa J, Clavero JA, Lorente M, Serra I, et al. Anatomy of the temporomandibular joint. In: Seminars in Ultrasound, CT and MRI: Elsevier; 2007. p. 170–83.
2.
Freund BJ, Schwartz M. Use of botulinum toxin in chronic whiplash-associated disorder. Clin J Pain. 2002;18(6 Suppl):S163–8.CrossRef
3.
Peck CC, Goulet JP, Lobbezoo F, Schiffman EL, Alstergren P, Anderson GC, et al. Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders. J Oral Rehabil. 2014;41(1):2–23.CrossRef
4.
Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet J-P, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the international RDC/TMD consortium network* and orofacial pain special interest group†. J Oral Facial Pain Headache. 2014;28(1):6–27.CrossRef
5.
Dimitroulis G. Management of temporomandibular joint disorders: a surgeon’s perspective. Aust Dent J. 2018;63:S79–90.CrossRef
6.
Derwich M, Lassmann L, Machut K, Zoltowska A, Pawlowska E. General characteristics, biomedical and dental application, and usage of chitosan in the treatment of temporomandibular joint disorders: a narrative review. Pharmaceutics. 2022;14(2):305.
7.
8.
Gauer R, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015;91(6):378–86.PubMed
9.
Lung J, Bell L, Heslop M, Cuming S, Ariyawardana A. Prevalence of temporomandibular disorders among a cohort of university undergraduates in Australia. J Investig Clin Dent. 2018;9(August 2017):1–5.
10.
Wu J, Huang Z, Chen Y, Chen Y, Pan Z, Gu Y. Temporomandibular disorders among medical students in China : prevalence, biological and psychological risk factors. BMC Oral Health. 2021;21:1–8.
11.
Medeiros RA De, Vieira DL, Vivianne E, Santos RW, Tabata LF. Prevalence of symptoms of temporomandibular disorders, oral behaviors, anxiety, and depression in Dentistry students during the period of social isolation due to COVID-19 Abstract. 2020;28:1–8.
12.
Emodi-Perlman A, Eli I, Smardz J, Uziel N, Wieckiewicz G, Gilon E, et al. Temporomandibular disorders and bruxism outbreak as a possible factor of orofacial pain worsening during the COVID-19 pandemic-concomitant research in two countries. J Clin Med. 2020;9(10):3250.
13.
Wieckiewicz M, Grychowska N, Nahajowski M, Hnitecka S, Kempiak K, Charemska K, et al. Prevalence and overlaps of headaches and pain-related temporomandibular disorders among the polish urban population. J Oral Facial Pain Headache. 2019;34:1–9.
14.
Valesan LF, Da-cas CD, Réus JC, Cristina A, Denardin S, Garanhani RR, et al. Prevalence of temporomandibular joint disorders : a systematic review and meta-analysis. Clin Oral Investig. 2021;25:441–53.
15.
Lins N, Arnaud M, Goretti M, Lima DS, Guimar S, Gomes F, et al. Prevalence of TMD and level of chronic pain in a group of Brazilian adolescents; 2019. p. 1–13.
16.
Wieckiewicz M, Grychowska N, Wojciechowski K, Pelc A, Augustyniak M, Sleboda A, et al. Prevalence and correlation between TMD based on RDC/TMD diagnoses, oral parafunctions and psychoemotional stress in Polish university students. Biomed Res Int. 2014;2014:472346.PubMedPubMedCentral
17.
Graue AM, Jokstad A, Assmus J, Skeie MS. Prevalence among adolescents in Bergen , Western Norway , of temporomandibular disorders according to the DC / TMD criteria and examination protocol. Acta Odontol Scand. 2016;6357(June):449–55.
18.
Mara F, Bertoli DP, Bruzamolin CD, Pizzatto E, Losso M, De SJF. Prevalence of diagnosed temporomandibular disorders : a cross-sectional study in Brazilian adolescents; 2018. p. 1–11.
19.
Sharma S, Breckons M, Brönnimann Lambelet B, Chung J, List T, Lobbezoo F, et al. Challenges in the clinical implementation of a biopsychosocial model for assessment and management of orofacial pain. J Oral Rehabil. 2020;47(1):87–100.CrossRef
20.
Ohrbach R, Dworkin SF. The evolution of TMD diagnosis: past, present, future. J Dent Res. 2016;95(10):1093–101.CrossRef
21.
Dıraçoǧlu D, Yıldırım NK, Saral I, Özkan M, Karan A, Özkan S, et al. Temporomandibular dysfunction and risk factors for anxiety and depression. J Back Musculoskelet Rehabil. 2016;29(3):487–91.CrossRef
22.
23.
Hegab AF, Ali HE, Elmasry M, Khallaf MG. Platelet-rich plasma injection as an effective treatment for temporomandibular joint osteoarthritis. J oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. 2015;73(9):1706–13.CrossRef
24.
Namera MO, Mahmoud G, Abdulhadi A, Burhan A. Effects of low-intensity pulsed ultrasound (LIPUS) applied on the temporomandibular joint (TMJ) region on the functional treatment of class II malocclusion: a randomized controlled trial. Dent Med Probl. 2020;57(1):53–60.CrossRef
25.
Madani A, Ahrari F, Fallahrastegar A, Daghestani N. A randomized clinical trial comparing the efficacy of low-level laser therapy (LLLT) and laser acupuncture therapy (LAT) in patients with temporomandibular disorders. Lasers Med Sci. 2020;35(1):181–92.CrossRef
26.
Florjanski W, Malysa A, Orzeszek S, Smardz J, Olchowy A, Paradowska-Stolarz A, et al. Evaluation of biofeedback usefulness in masticatory muscle activity management-a systematic review. J Clin Med. 2019;8(6):766.
27.
Nitecka-Buchta A, Nowak-Wachol A, Wachol K, Walczyńska-Dragon K, Olczyk P, Batoryna O, et al. Myorelaxant effect of transdermal Cannabidiol application in patients with TMD: a randomized, double-blind trial. J Clin Med. 2019;8(11):1886.
28.
Nitecka-buchta A, Buchta P, Tabeńska-Bosakowska E, Walczyńska-Dragoń K, Baron S. Myorelaxant Effect of Bee Venom Topical Skin Application in Patients with RDC / TMD Ia and RDC / TMD Ib : a randomized , double blinded study, vol. 2014; 2014. p. 9–12.
29.
Sung S, Kim D, Park M, Hwang S, Yoon Y, Park J. Electroacupuncture for temporomandibular disorders : a systematic review of randomized controlled trials; 2021. p. 1–13.
30.
Park H-B, Yang J-H, Chung K-H. Characterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: upregulation of matrix metalloproteinase-1 and-9 in HaCaT cells. Korean J Hematol. 2011;46(4):265–73.CrossRef
31.
Alkerdi K, Alsabek L, Alkhouli M, Al-Nerabieah Z, Jaafo H. Evaluation of the effect of injectable platelet-rich fibrin (I-PRF) in reducing the resorption of fat graft during facial lipostructure: a randomized clinical trial. Dent Med Probl. 2022;59(1):131–6.CrossRef
32.
Bhattacharya HS, Gummaluri SS, Astekar M, Gummaluri RK. Novel method of determining the periodontal regenerative capacity of T-PRF and L-PRF: an immunohistochemical study. Dent Med Probl. 2020;57(2):137–44.CrossRef
33.
Pietruszka P, Chruścicka I, Duś-Ilnicka I, Paradowska-Stolarz A. PRP and PRF-subgroups and divisions when used in dentistry. J Pers Med. 2021;11(10):944.
34.
Kavadar G, Demircioglu DT, Celik MY, Emre TY. Effectiveness of platelet-rich plasma in the treatment of moderate knee osteoarthritis: a randomized prospective study. J Phys Ther Sci. 2015;27(12):3863–7.CrossRef
35.
Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res. 2006;17(2):212–9.CrossRef
36.
Albanese A, Licata ME, Polizzi B, Campisi G. Platelet-rich plasma (PRP) in dental and oral surgery: from the wound healing to bone regeneration. Immun Ageing. 2013;10(1):1–10.CrossRef
37.
Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig. 2017;21(8):2619–27.CrossRef
38.
Fujioka-Kobayashi M, Katagiri H, Kono M, Schaller B, Zhang Y, Sculean A, et al. Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols. Clin Oral Investig. 2020;24(12):4373–83.
39.
McCain JP, Hossameldin RH. Advanced arthroscopy of the temporomandibular joint. Atlas Oral Maxillofac Surg Clin North Am. 2011;19(2):145–67.CrossRef
40.
Helkimo M. Studies on function and dysfunction of the masticatory system. IV. Age and sex distribution of symptoms of dysfunction of the masticatory system in Lapps in the north of Finland. Acta Odontol Scand. 1974;32(4):255–67.CrossRef
41.
Gupta S, Sharma A, Purohit J, Goyal R, Malviya Y, Jain S. Comparison between intra-articular platelet-rich plasma injection versus hydrocortisone with local anesthetic injections in temporomandibular disorders: a double-blind study. Natl J Maxillofac Surg. 2018;9(2):205–8.CrossRef
42.
Hancı M, Karamese M, Tosun Z, Aktan TM, Duman S, Savaci N. Intra-articular platelet-rich plasma injection for the treatment of temporomandibular disorders and a comparison with arthrocentesis. J Cranio Maxillo Facial Surg Off Publ Eur Assoc Cranio Maxillo Facial Surg. 2015;43(1):162–6.CrossRef
43.
Harba AN, Harfoush M. Evaluation of the participation of hyaluronic acid with platelet-rich plasma in the treatment of temporomandibular joint disorders. Dent Med Probl. 2021;58(1):81–8.CrossRef
Metadata
Title
Evaluation of the efficacy of platelet rich fibrin (I-PRF) intra-articular injections in the management of internal derangements of temporomandibular joints – a controlled preliminary prospective clinical study
Authors
Mustafa Manafikhi
Jawdat Ataya
Omar Heshmeh
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2022
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-022-05421-7

Other articles of this Issue 1/2022

BMC Musculoskeletal Disorders 1/2022 Go to the issue

Research

Comparative analysis of arthroscopic-assisted Tight-rope technique and clavicular hook plate fixation in the treatment of Neer type IIB distal clavicle fractures

Research

Fat infiltration of paraspinal muscles as an independent risk for bone nonunion after posterior lumbar interbody fusion

Research

The progression of the vertebral body bruise associated with a spinal fracture

Research

The impact of sarcopenia on low back pain and quality of life in patients with osteoporosis

Research

Classification and reconstruction of femoral bone defect in the revision of aseptic loosening of distal femoral endoprostheses: a 10-year multicenter retrospective analysis

Research

Influence of hyaluronic acid on intra-articular friction – a biomechanical study in whole animal joints